| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |